Angiogenesis, Inflammation & Therapeutics | Online ISSN  2207-872X
CASE STUDY   (Open Access)

Cardiovascular Manifestations of Leptospirosis: A Case of Myopericarditis in an Endemic Region

Jayakanthan S 1, Manimaran R 1, Sathyanarayanan M 1*, Bharathi Raja K 1

+ Author Affiliations

Journal of Angiotherapy 5 (2) 1-4 https://doi.org/10.25163/angiotherapy.52621722920201221

Submitted: 29 November 2021 Revised: 11 December 2021  Published: 22 December 2021 


Abstract

Background: Leptospirosis, caused by the spirochete bacterium Leptospira, is predominantly recognized for its systemic manifestations involving the liver, kidneys, and central nervous system. Cardiovascular involvement, though less common, is frequently underestimated and may lead to severe complications if not addressed promptly. Methods: This case study reports on a 45-year-old male laborer from Chengalpattu, Tamil Nadu, an endemic area for leptospirosis. The patient initially presented with fever, headache, and myalgias. Diagnosis was confirmed through positive IgM antibodies and Microscopic Agglutination Test (MAT). Following initial treatment with doxycycline, the patient experienced mild chest pain and was admitted a week later. Diagnostic procedures included echocardiography and electrocardiography (ECG), which identified pericardial fluid, pericardial thickening, supraventricular arrhythmias, and elevated cardiac biomarkers. Results: Echocardiography revealed approximately 200 cc of pericardial fluid without cardiac tamponade and pericardial thickening. The ECG showed supraventricular arrhythmias and elevated cardiac biomarkers, including Creatine Phosphokinase (CPK) and Troponin I. These findings suggested acute myopericarditis secondary to leptospirosis. The patient was treated with anti-inflammatory medications, including NSAIDs, colchicine, and low-dose corticosteroids. Conclusion: This case underscores the importance of considering cardiovascular involvement in leptospirosis, particularly in endemic areas. Although rare, leptospirosis can present with severe cardiac complications such as myopericarditis. Comprehensive follow-up, including ECG and cardiac enzyme monitoring, is essential for managing potential complications and ensuring favorable patient outcomes. Early recognition and appropriate treatment are crucial to addressing these rare but serious manifestations of leptospirosis.

Keywords: Leptospirosis, Myopericarditis, Cardiovascular involvement, Endemic regions, Cardiac biomarkers

Introduction

GO

A 45-year-old Alexander, who came from Chengalpattu endemic area for leptospirosis and Malaria. Initially he presented to the Hospital with high-grade fever, headache, and myalgias, and he was tested for Leptospirosis, confirmed by positive Leptospira IgM, negative IgG, and highly positive Microscopic Agglutination Test, and indicated doxycycline (for 6 days course). He was admitted with mild chest pain, severe lower limb edema, acute headache, polymyalgia, and foamy urine. Although, on admission we ruled out any hepatic, kidney, pulmonary, and cardiac complications, at that point, he was presenting a leptospirosis infection.

On examination

Patient in poor general condition, b/l lower limb edema, eyes look red.  

Cardiovascular: Rhythm, tachycardia, no murmurs; All other system examination is unremarkable.

 

Laboratory

Elisa for leptospirosis: Microagglutination reagent in tube (MAT); Leptospirosis: Autummalis 1/400/Canicola 1/200; Chest X-ray: Increased cardiac silhouette with atrial effacement and right ventricle edges. He presented with chest pain and echocardiography: pericardial fluid (approximately 200 cc) with no cardiac tamponade, thickening of visceral and parietal (+/- 5mm) pericardium and electrocardiogram shows simple and aberrant supraventricular arrhythmia with isolated extrasystoles and raised cardiac enzymes (Creatine phosphokinase: 800 U/L, Creatine phosphokinase-M: 5 ng/ml, Myoglobin: 143 ng/ml and Troponin I: 0.9 ng/ml) Proteinuria: 0.86g/24h.

Leptospirosis with chest pain associated with the laboratory and imaging and the Reactive MAT, gives a differential diagnosis of rare manifestation of Myopericarditis due to Severe Leptospira. In addition, other infective and autoimmune aetiologies were excluded, such as dengue haemorrhagic fever or other arboviruses, autoimmune multi-system disorders such as systemic lupus erythematosus, and vasculitis were also differentiated. The patient recovered with antibiotics and anti-inflammatory medication to ensure the pericardial complication.

Discussion

GO

Leptospirosis is a generalized, systemic disease, mainly Vascular lesion, affecting predominantly capillaries is a characteristic feature of leptospirosis and responsible for edema and haemorrhagic diathesis. Therefore, highly sensitive and specific MAT is the gold standard serological test for the high positive diagnosis in this patient (Jorge et al., 2014).

Multiple factors may cause clinical manifestations that suggest cardiac involvement. Multiple electrocardiographic changes occur in leptospirosis, very commonly atrial fibrillation, atrioventricular conduction blocks and non-specific ventricular repolarization abnormalities. The diagnostic value of echocardiographic evidence and cardiac biomarkers is unknown (Andre, 2000).

There is no specific management to prevent or treat cardiac involvement in leptospirosis; In this patient, we started anti-inflammatory treatment for pericarditis which has been well defined with first-line agents represented by NSAIDS drugs and colchicine, second-line agents, low-dose corticosteroids (slow tapering), and for specific indications (Abdulkader et al., 2002).

In this case, at first cardiac complication is not present. The disease Leptospira Interorgan has two clinical stages, and it is specifically in the second week of disease, immune phase. Follow-up is compulsory for at least 4 weeks after the febrile stage in patients with a confirmed diagnosis of Leptospirosis, because patients can decompensate and are predisposed to get complicated. Thus, this case is the report of leptospirosis presenting acute myocarditis and pericarditis due to Leptospirosis.

Conclusion

GO

In conclusion, leptospirosis is a cause of myopericarditis in endemic places. In addition, Leptospira causes several cases of idiopathic myocarditis. If the patient has leptospirosis, we should always consider cardiac involvement, take an ECG, cardiac enzymes and rule out cardiovascular involvement.

Author contribution

GO

Jayakanthan S, Manimaran R, Sathyanarayanan M, Bharathi Raja K encouraged and supervised the findings of this work. All authors discussed the results and contributed to the final manuscript.

References


Abdulkader, R. C., Daher, E. F., Camargo, E. D., Spinosa, C., & da Silva, M. V. (2002). Leptospirosis severity may be associated with the intensity of humoral immune response. Revista do Instituto de Medicina Tropical de São Paulo, 44(2), 79-83. https://doi.org/10.1590/S0036-46652002000200005

Andre, V., Lomar, D., Diament, D., & Torres, J. R. (2000). Leptospirosis in Latin America. In Emerging and re-emerging diseases in Latin America (Infectious Disease Clinics, Vol. 14, pp. 23-39). https://doi.org/10.1016/S0891-5520(05)70216-6

Assimakopoulos, S. F., Michalopoulou, S., Papakonstantinou, C., Lekkou, A., Syrokosta, I., & Gogos, C. (2007). A case of severe sinus bradycardia complicating anicteric leptospirosis. The American Journal of the Medical Sciences, 333(6), 381-383.

Chin, V. K., Basir, R., Nordin, S. A., Abdullah, M., & Sekawi, Z. (2020). Pathology and host immune evasion during human leptospirosis: A review. International Microbiology, 23(2), 127-136.

Chin, V. K., Lee, T. Y., Lim, W. F., & others. (2018). Leptospirosis in humans: Biomarkers in host immune responses. Microbiological Research, 207, 108-115.

Constans, J., Gosse, P., Cottarre, M., Ansoborlo, P., & Mercie, P. (1996). Myopericarditis and atrial fibrillation disclosing leptospirosis septicemia. Presse Médicale, 25, 555.

Galluzzo, A., & Imazio, M. (2018). Advances in medical therapy for pericardial diseases. Expert Review of Cardiovascular Therapy, 16(9), 635-643. https://doi.org/10.1080/14779072.2018.1510315

Gomes, A. P., Gazola, D. M., Braga, L. M., da Motta, O. J., & Gazineo, J. L. (2022). Leptospirosis: An update-part 1 of 2: Etiology, ecology, epidemiology, prophylaxis and control. Brazilian Journal of Health Review, 5(3), 11361-11372.

Jesrani, G., Gupta, S., Gaba, S., & Gupta, M. (2022). Electrocardiographic abnormalities in prevalent infections in tropical regions: A scoping review. Journal of Acute Disease, 11(2), 45-51.

Jorge, O. A.-V., Romani-Romani, F., Tejada, R. A., Wong-Chero, P., & Céspedes-Zambrano, M. (2014). Seroprevalencia de leptospirosis y características asociadas en agricultores de arroz de una región tropical del Peru. Revista Peruana de Medicina Experimental y Salud Pública, 31(2), 195-203. https://doi.org/10.17843/rpmesp.2014.312.35

Khalili, M., Sakhaee, E., Amiri, F. B., Safat, A. A., Afshar, D., & Esmaeili, S. (2020). Serological evidence of leptospirosis in Iran: A systematic review and meta-analysis. Microbial Pathogenesis, 138, 103833.

Lucht, F., Lafond, P., & Bertrand, J. C. (1996). Myopericarditis and auricular fibrillation disclosing septicemic leptospirosis. Presse Médicale, 25, 1805.

Mathew, A., Shanks, M., Punnoose, E., & others. (2020). Cardiac involvement in critically ill patients with leptospirosis: A prospective study using myocardial deformation imaging. European Heart Journal: Acute Cardiovascular Care, 9(8), 975-983.

Shah, K., Amonkar, G. P., Kamat, R. N., & Deshpande, J. R. (2010). Cardiac findings in leptospirosis. Journal of Clinical Pathology, 63(2), 119-123. https://doi.org/10.1136/jcp.2009.069575

Škerk, V., Markotic, A., Puljiz, I., Kuzman, I., & Celjuska ToŠev, E. (2011). Electrocardiographic changes in hospitalized patients with leptospirosis over a 10-year period. Medical Science Monitor, 17(6), 369-375. https://doi.org/10.12659/MSM.881847

Swarath, S., Maharaj, N., Seecheran, R., & others. (2023). Leptospirosis-induced myocarditis and arrhythmias. Journal of Investigative Medicine High Impact Case Reports, 11, 1-5.

Trivedi, S. V., Bhattacharya, A., Amichandwala, K., & Jakkamsetti, V. (2003). Evaluation of cardiovascular status in severe leptospirosis. Journal of the Association of Physicians of India, 51, 951-954.

Vernel-Pauillac, F., & Werts, C. (2018). Recent findings related to immune responses against leptospirosis and novel strategies to prevent infection. Microbes and Infection, 20(9-10), 578-588.

Warrier, R., Singh, S. K., Singh, S., & others. (2018). Junctional rhythm: A rare sign in leptospirosis. Indian Journal of Critical Care Medicine, 22(12), 889-891.

PDF
Abstract
Export Citation

View Dimensions


View Plumx


View Altmetric




Save
0
Citation
597
View

Share